Try our Advanced Search for more refined results

Sanofi Wins Injunction In Sun IP Suit Over Eloxatin

By Sherry Mazzocchi ( February 17, 2011, 8:53 PM EST) -- Sanofi-Aventis LLC won a preliminary injunction barring Sun Pharmaceuticals Industries Ltd. from selling a generic version of Sanofi's colon cancer drug Eloxatin, after an agreement between the parties to temporarily halt Sun's sales of the drug expired earlier this week....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!